Friday, July 31, 2015 10:19:47 PM
Gerald Finken revamping his linkedin profile:
------------------
Gerald Finken:
Summary
My passion for the practice of pharmacy began immediately after I graduated from pharmacy school and learned all of the ways a pharmacist can positively influence a patient's life. For over 33 years, this passion and drive has motivated me to bring the practice of pharmacy into the clinical research sector. I have always challenged traditional clinical trial models and through new processes, innovative study designs, and patient counseling services, I have been able to revolutionize the way patients receive and take their medications in clinical trials.
With the mission of making a difference in the clinical supplies sector, I founded CSM in 1997 and grew the company from a one-person consulting operation, to a multi-million dollar organization with multiple locations and 100+ employees. In 2001, I created and launched the On-Demand packaging and labeling platform, an industry breakthrough enabling a flexible clinical supply chain to keep pace with breakthrough therapies, diagnostics, and technology by delivering patient-centric medication.
While working with sponsor companies and seeing first-hand the struggle of getting FDA approval, I launched CTRP® (Clinical Trials Research Pharmacist) services as a division of CSM. By piloting this services through CSM, we were able to prove that pharmacists counseling patients in clinical trials can improve compliance, adherence, retention, and more importantly, the overall quality of the studies. In 2014, I rebranded and re-launched the CTRP® service through Center Point Clinical Services, LLC.
Both Center Point and CSM are re-defining the way our industry conducts clinical trials with the overall strategy of finding innovative solutions to help companies decrease timelines, improve study outcomes, and reduce costs while improving the strategic quality in all aspects of patient-centric medication and care.
Experience:
CEO & Founder
Center Point Clinical Services LLC
July 2013 – Present (2 years 2 months)
At Center Point, we focus on patient engagement, providing a groundbreaking Clinical Trials Research Pharmacist (CTRP®) service, in which patients enrolled in clinical trials are paired with one of our highly trained pharmacists. Giving patients access to professional counseling and education leads to an optimal clinical trial experience, which dramatically increases patient satisfaction, retention, and compliance.
President, CEO & Founder
CSM
January 1997 – Present (18 years 8 months)Fargo, North Dakota Area,
At CSM, we help companies overcome complex clinical supply challenges such as limited drug supply, short timelines and study complexity. Offering a blend of unique and innovative services, such as On-Demand Packaging and Labeling and Direct-to-Patient, our clients are able to reduce supply costs, shorten timelines, and improve study outcomes.
(Open)1 organization
(Open)1 honor or award
Staff Pharmacist
Veterans Administration Hospital
June 1995 – May 1997 (2 years)Fargo, North Dakota Area
Independent Consultant
CSM
May 1995 – December 1996 (1 year 8 months)Fargo, North Dakota Area
Director, Clinical Supply Services
PRACS Institute
March 1993 – May 1995 (2 years 3 months)Fargo, North Dakota Area
Manager, Clinical Investigational Drug Management
Bristol-Myers Squibb
June 1982 – August 1993 (11 years 3 months)Princeton, NJ
https://www.linkedin.com/pub/gerald-finken/5/190/957
Tina Schlecht:
https://www.linkedin.com/pub/tina-schlecht/2a/409/397
------------------------------------------------
Interesting that there is no mention from Peregrine (yet) about the lawsuits vs CSM and access to all the full depositions in their entirety are being blocked.... we shall see...
This was from a previous post... and original thoughts...
....................................................
IMO these two Finken and Schlecht had something to do with the outcome of the PPHM PII NSCLC clinical trial. I did some research a while back and found these patents.
SYSTEM AND METHOD FOR LABELING TRIAL STUDY MATERIALS
http://www.patentbuddy.com/Patent/20140237950
Kristina Schlecht related to Tina Schlecht who is President of Center Point ??!! and also... ex-CSM
Vice President, Retention and Compliance Services
CSM
2003 – 2006 (3 years)
Director, Pharmaceutical Care Services
CSM
2002 – 2003 (1 year)
Director, Business Development
CSM
2000 – 2002 (2 years)
https://www.linkedin.com/pub/tina-schlecht/2a/409/397
-----------
whom is also related to Shannon Schlecht and Sheila Schlecht and oh my... the puzzle pieces just keep in piling on
"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline." -- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!
Recent CDMO News
- Avid Bioservices to Participate in Craig-Hallum Bioprocessing Conference • GlobeNewswire Inc. • 09/12/2024 08:05:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 09/09/2024 08:43:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/09/2024 08:19:30 PM
- Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2024 • GlobeNewswire Inc. • 09/09/2024 08:05:31 PM
- U.S. Futures Rise Amid Inflation Report Anticipation; Oil Prices Climb on Hurricane Threat and Supply Concerns • IH Market News • 09/09/2024 10:09:14 AM
- Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2025 After Market Close on September 9, 2024 • GlobeNewswire Inc. • 09/03/2024 08:05:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/29/2024 08:30:10 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 08/28/2024 08:34:04 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 08/28/2024 08:32:18 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 08/28/2024 08:30:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/16/2024 11:50:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/16/2024 11:48:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/15/2024 08:40:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/12/2024 08:30:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/11/2024 09:02:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/11/2024 09:02:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/11/2024 09:01:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/11/2024 09:01:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/11/2024 09:00:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/11/2024 09:00:45 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/11/2024 12:23:26 AM
- Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2024 • GlobeNewswire Inc. • 07/02/2024 08:05:04 PM
- Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2024, After Market Close on July 2, 2024 • GlobeNewswire Inc. • 07/01/2024 11:00:21 AM
- Avid Bioservices Earns Committed Badge from EcoVadis for Sustainability Performance • GlobeNewswire Inc. • 05/23/2024 12:05:46 PM
- Avid Bioservices to Participate at Upcoming Investor Conferences • GlobeNewswire Inc. • 05/07/2024 08:05:11 PM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM